AI Article Synopsis

  • * A clinical evaluation and skin biopsy revealed that he had cutaneous small-vessel vasculitis (CSVV), leading to the stopping of the medication and the start of treatment with oral methylprednisolone.
  • * The rash improved within a week, emphasizing the need for quick identification and treatment of drug-induced CSVV, and contributing to the limited research on side effects associated with selective serotonin reuptake inhibitors (SSRIs) like escitalopram.

Article Abstract

A 65-year-old male with multiple comorbidities and recently diagnosed with diabetic kidney disease developed upper and lower extremity rash following escitalopram initiation for his depressive mood. Clinical assessment and skin biopsy confirmed cutaneous small-vessel vasculitis (CSVV), prompting drug discontinuation and oral methylprednisolone therapy. The resolution of the rash was achieved within a week. This rare case of CSVV induced by escitalopram highlights the importance of timely recognition and management of drug-induced CSVV and adds to the limited literature on selective serotonin reuptake inhibitor-associated CSVV.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11189275PMC
http://dx.doi.org/10.7759/cureus.62776DOI Listing

Publication Analysis

Top Keywords

cutaneous small-vessel
8
small-vessel vasculitis
8
induced escitalopram
8
vasculitis induced
4
escitalopram case-based
4
case-based review
4
review literature
4
literature 65-year-old
4
65-year-old male
4
male multiple
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!